Lmf Acquisition Opportunities Inc LMAO
We take great care to ensure that the data presented and summarized in this overview for LMF Acquisition Opportunities Inc is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in LMAO
Top Purchases
Top Sells
About LMAO
LMF Acquisition Opportunities, Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Tampa, Florida.
Insider Transactions at LMAO
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 11
2024
|
John Neuman |
BUY
Open market or private purchase
|
Direct |
10,000
+20.0%
|
$20,000
$2.04 P/Share
|
|
Nov 18
2024
|
Kevin Chung Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
4,250
+23.7%
|
$4,250
$1.99 P/Share
|
|
Sep 30
2024
|
Kevin Chung Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+9.58%
|
$4,000
$4.26 P/Share
|
|
Aug 30
2024
|
David A Green Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,100
+43.97%
|
-
|
|
Aug 15
2024
|
John Neuman |
BUY
Open market or private purchase
|
Direct |
10,000
+25.0%
|
$50,000
$5.24 P/Share
|
|
Jun 17
2024
|
John Neuman |
BUY
Open market or private purchase
|
Direct |
10,000
+33.33%
|
$40,000
$4.35 P/Share
|
|
Jun 14
2024
|
John Neuman |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$30,000
$3.69 P/Share
|
|
Apr 18
2024
|
David A Green Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,223
+50.0%
|
-
|
|
Apr 12
2024
|
David A Green Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
752,500
+50.0%
|
-
|
|
Apr 12
2024
|
Rick Barnett |
BUY
Grant, award, or other acquisition
|
Direct |
70,264
+44.77%
|
-
|
|
Apr 12
2024
|
Andres Lobo |
BUY
Grant, award, or other acquisition
|
Direct |
32,322
+44.51%
|
-
|
|
Apr 12
2024
|
Richard D. Russell |
BUY
Grant, award, or other acquisition
|
Direct |
32,322
+34.9%
|
-
|
|
Apr 12
2024
|
Allan Collins |
BUY
Grant, award, or other acquisition
|
Direct |
37,943
+41.11%
|
-
|
|
Apr 12
2024
|
Kenneth Van Heel |
BUY
Grant, award, or other acquisition
|
Direct |
43,564
+21.4%
|
-
|
|
Apr 12
2024
|
Bruce M. Rodgers |
BUY
Grant, award, or other acquisition
|
Direct |
36,537
+45.08%
|
-
|
|
Nov 29
2023
|
Caryl Baron Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
20,293
+12.67%
|
-
|
|
Nov 29
2023
|
Kevin Chung Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,422
+23.12%
|
-
|
|
Nov 29
2023
|
Eric Schlorff Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,248
+6.71%
|
-
|
|
Nov 22
2023
|
Kenneth Van Heel |
BUY
Open market or private purchase
|
Direct |
100,000
+46.21%
|
$0
$0.4 P/Share
|
|
Sep 22
2023
|
Caryl Baron Interim CFO |
BUY
Other acquisition or disposition
|
Direct |
15,070
+11.19%
|
-
|
Last 12 Months Summary
Buy / Acquisition
1.06M
Shares
From
9
Insiders
| Grant, award, or other acquisition | 1.02M shares |
|---|---|
| Open market or private purchase | 45.3K shares |
Sell / Disposition
0
Shares
From
0
Insiders